Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
In the waiting room for the print doctor are No. 2- and No. 8-ranked medical/pharma ($471B, +5 percent; with $14.6B to print, +8 percent) and health providers ($3.25T, +5 percent; with $9.5B to print, +5 percent). Selling sickness and dysfunction are the only prescriptions for increased revenues for otherwise ailing pharmaceutical companies with few new drugs in development.
0 Comments
View Comments
E
Vincent Mallardi
Author's page
Vincent Mallardi, C.M.C., is a the chairman of the Printing Brokerage/Buyers Association International (PBBA) and is a Certified Management Consultant in the paper, printing and converting industries. He is also an adjunct professor in economics. Contact him via email at vince@pbba.org
Related Content
Comments